Updated:
Beijing Beilu Pharmaceutical
Beijing Beilu Pharmaceutical was established in 1992 by Wang Weidong. Xu Wang serves as current Chairman and General Manager. The firm developed from...
Beijing Beilu Pharmaceutical
Beijing Beilu Pharmaceutical was established in 1992 by Wang Weidong. Xu Wang serves as current Chairman and General Manager. The firm developed from pharmaceutical manufacturing into a corporate investor structure. The company allocates across an Industry Buyout Fund and direct holdings. Confirmed co-investors include Chongqing Sanxia Paints Co., Ltd. at 6.12 percent and China Resources YuKang Asset Management Co., Ltd. at 2.66 percent. Geographic reach centers on China with production sites in Beijing, Hebei Province and Zhejiang Province. No recent operational events from the last 24 months appear in available records. The firm maintains three dedicated production facilities and headquarters in Haidian District, Beijing. It holds recognition from Beijing municipal lists for private enterprise growth and social responsibility. Ownership remains tied to the founding operator and listed corporate shareholders rather than external limited partners.
General information
Firm type
Corporate Investor
Year founded
1992
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Beijing
Corporate office
Maples International Office Block A, 7th Floor, No. 32 Xizhimen North Street, Haidian District, Beijing, 100082, China
Principals
Wang Weidong
Founder
Xu Wang
Chairman and General Manager
Sector focus
Frequently asked questions
Who runs investment decisions at Beijing Beilu Pharmaceutical?
Xu Wang holds the role of Chairman and General Manager. Wang Weidong founded the firm in 1992.
Does Beijing Beilu Pharmaceutical participate in fund commitments or only direct deals?
The firm maintains an Industry Buyout Fund based in Beijing. It also holds direct equity positions through named co-investors.
Where does the underlying wealth come from?
Wealth originates from pharmaceutical product development, production and sales. The company listed on the Shenzhen Stock Exchange in 2009.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: